Interesting connection blafarm. No doubt there are plenty of indications and a mountain of upside here. I think we all really want to get the first indication under our belt. I think some of us (myself included) often suffer from "indication fatique."

I remember on the investor call where the Vyera deal was announced, just before they announced it they mentioned that they were beginning studies into MS. And my knee jerk reaction was "great, another indication. Get a deal done!"

Speaking of other indications, i wonder whats happening with the new Nash animal trial that started a couple of months back. Thats another massive opportunity.